Attorneys:
A team of Ropes & Gray attorneys advised Synageva BioPharma Corp. on the company’s offering of 2,472,500 shares of its common stock at a price of $47.53 per share, closed on January 9th. Synageva is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need.
The Ropes & Gray team was led by securities & public companies partner Paul Kinsella, and included securities & public companies associates Zach Blume and paralegal Drew Fishback.
The Ropes & Gray team was led by securities & public companies partner Paul Kinsella, and included securities & public companies associates Zach Blume and paralegal Drew Fishback.
Attorneys
Stay Up To Date with Ropes & Gray
Subscribe to Our Podcast
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Follow Us on Social
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
Join Our Mailing List
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.